Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients

COLUMBUS, Ohio & LOS ANGELES--(BUSINESS WIRE)-- #clinicalresearch--Beverly Hills Cancer Center and Deep Lens today announced a strategic collaboration that will deploy Deep Lens’ AI-based clinical trial matching solution VIPER™ and other services into one of Southern California’s few private cancer centers. VIPER uses proprietary cloud-based technology to identify and match...

Click to view original post